165 related articles for article (PubMed ID: 38272233)
21. Pharmacokinetic characterization of kalata B1 and related therapeutics built on the cyclotide scaffold.
Poth AG; Huang YH; Le TT; Kan MW; Craik DJ
Int J Pharm; 2019 Jun; 565():437-446. PubMed ID: 31063836
[TBL] [Abstract][Full Text] [Related]
22. Isolation, solution structure, and insecticidal activity of kalata B2, a circular protein with a twist: do Möbius strips exist in nature?
Jennings CV; Rosengren KJ; Daly NL; Plan M; Stevens J; Scanlon MJ; Waine C; Norman DG; Anderson MA; Craik DJ
Biochemistry; 2005 Jan; 44(3):851-60. PubMed ID: 15654741
[TBL] [Abstract][Full Text] [Related]
23. Insights into processing and cyclization events associated with biosynthesis of the cyclic Peptide kalata B1.
Conlan BF; Colgrave ML; Gillon AD; Guarino R; Craik DJ; Anderson MA
J Biol Chem; 2012 Aug; 287(33):28037-46. PubMed ID: 22700963
[TBL] [Abstract][Full Text] [Related]
24. Dynamic scenario of membrane binding process of kalata b1.
Nawae W; Hannongbua S; Ruengjitchatchawalya M
PLoS One; 2014; 9(12):e114473. PubMed ID: 25473840
[TBL] [Abstract][Full Text] [Related]
25. Exploring the Limits of Cyanobactin Macrocyclase PatGmac: Cyclization of PawS-Derived Peptide Sunflower Trypsin Inhibitor-1 and Cyclotide Kalata B1.
Muhammad T; Houssen WE; Thomas L; Alexandru-Crivac CN; Gunasekera S; Jaspars M; Göransson U
J Nat Prod; 2023 Mar; 86(3):566-573. PubMed ID: 36917740
[TBL] [Abstract][Full Text] [Related]
26. The N-terminal pro-domain of the kalata B1 cyclotide precursor is intrinsically unstructured.
Daly NL; Gunasekera S; Clark RJ; Lin F; Wade JD; Anderson MA; Craik DJ
Biopolymers; 2016 Nov; 106(6):825-833. PubMed ID: 27564841
[TBL] [Abstract][Full Text] [Related]
27. Efficient Enzymatic Cyclization of Disulfide-Rich Peptides by Using Peptide Ligases.
Schmidt M; Huang YH; Texeira de Oliveira EF; Toplak A; Wijma HJ; Janssen DB; van Maarseveen JH; Craik DJ; Nuijens T
Chembiochem; 2019 Jun; 20(12):1524-1529. PubMed ID: 30735312
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.
Cascales L; Henriques ST; Kerr MC; Huang YH; Sweet MJ; Daly NL; Craik DJ
J Biol Chem; 2011 Oct; 286(42):36932-43. PubMed ID: 21873420
[TBL] [Abstract][Full Text] [Related]
29. Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism.
Gründemann C; Thell K; Lengen K; Garcia-Käufer M; Huang YH; Huber R; Craik DJ; Schabbauer G; Gruber CW
PLoS One; 2013; 8(6):e68016. PubMed ID: 23840803
[TBL] [Abstract][Full Text] [Related]
30. A Synthetic mirror image of kalata B1 reveals that cyclotide activity is independent of a protein receptor.
Sando L; Henriques ST; Foley F; Simonsen SM; Daly NL; Hall KN; Gustafson KR; Aguilar MI; Craik DJ
Chembiochem; 2011 Nov; 12(16):2456-62. PubMed ID: 21928440
[TBL] [Abstract][Full Text] [Related]
31. Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.
Plan MR; Rosengren KJ; Sando L; Daly NL; Craik DJ
Biopolymers; 2010; 94(5):647-58. PubMed ID: 20564013
[TBL] [Abstract][Full Text] [Related]
32. Linearization of a naturally occurring circular protein maintains structure but eliminates hemolytic activity.
Barry DG; Daly NL; Clark RJ; Sando L; Craik DJ
Biochemistry; 2003 Jun; 42(22):6688-95. PubMed ID: 12779323
[TBL] [Abstract][Full Text] [Related]
33. Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle.
Shenkarev ZO; Nadezhdin KD; Sobol VA; Sobol AG; Skjeldal L; Arseniev AS
FEBS J; 2006 Jun; 273(12):2658-72. PubMed ID: 16817894
[TBL] [Abstract][Full Text] [Related]
34. Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design.
Clark RJ; Daly NL; Craik DJ
Biochem J; 2006 Feb; 394(Pt 1):85-93. PubMed ID: 16300479
[TBL] [Abstract][Full Text] [Related]
35. Computational Design of Hypothetical New Peptides Based on a Cyclotide Scaffold as HIV gp120 Inhibitor.
Sangphukieo A; Nawae W; Laomettachit T; Supasitthimethee U; Ruengjitchatchawalya M
PLoS One; 2015; 10(11):e0139562. PubMed ID: 26517259
[TBL] [Abstract][Full Text] [Related]
36. An asparaginyl endopeptidase mediates in vivo protein backbone cyclization.
Saska I; Gillon AD; Hatsugai N; Dietzgen RG; Hara-Nishimura I; Anderson MA; Craik DJ
J Biol Chem; 2007 Oct; 282(40):29721-8. PubMed ID: 17698845
[TBL] [Abstract][Full Text] [Related]
37. Making Ends Meet: Microwave-Accelerated Synthesis of Cyclic and Disulfide Rich Proteins Via In Situ Thioesterification and Native Chemical Ligation.
Gunasekera S; Aboye TL; Madian WA; El-Seedi HR; Göransson U
Int J Pept Res Ther; 2013 Mar; 19(1):43-54. PubMed ID: 23504256
[TBL] [Abstract][Full Text] [Related]
38. Papain-like cysteine proteases prepare plant cyclic peptide precursors for cyclization.
Rehm FBH; Jackson MA; De Geyter E; Yap K; Gilding EK; Durek T; Craik DJ
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7831-7836. PubMed ID: 30944220
[TBL] [Abstract][Full Text] [Related]
39. Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis.
Jennings C; West J; Waine C; Craik D; Anderson M
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10614-9. PubMed ID: 11535828
[TBL] [Abstract][Full Text] [Related]
40. Cyclotides: Disulfide-rich peptide toxins in plants.
Huang YH; Du Q; Craik DJ
Toxicon; 2019 Oct; 172():33-44. PubMed ID: 31682883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
